Top-News
Professionelle Dienstleistungen USA

Sana Biotechnology Inc News

Aktie
WKN:  A2QNUE ISIN:  US7995661045 US-Symbol:  SANA
6,115 $
-1,045 $
-14,59%
14.06.24 21:58:34
Handeln Depot/Watchlist
Aktienanzahl *
220,45 Mio.
Marktkapitalisierung *
1,25 Mrd. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 05.03.2024

Sana Biotechnology Inc News

27.11.23 - PR Newswire
Flagship Pioneering Marks Official Opening of UK Hub with Event Convening Life Science Leaders
Flagship Pioneering Marks Official Opening of UK Hub with Event Convening Life Science Leaders PR Newswire
21.11.23 - PR Newswire
Flagship Pioneering Unveils Quotient Therapeutics to Create Transformative Medicines Informed by a New Frontier of Genetics
Flagship Pioneering Unveils Quotient Therapeutics to Create Transformative Medicines Informed by a New Frontier of Genetics PR Newswire
17.11.23 - GlobeNewswire
Uppsala University Hospital and Sana Biotechnology Announce Authorization of the First-in-Human Clinical Trial Application for a Primary Islet Cell Treatment for Patients with Type 1 Diabetes
Goal is to report UP421 proof of concept data in 2023 and 2024
01.11.23 - PR Newswire
Flagship Pioneering Launches Pioneering Intelligence
Flagship Pioneering Launches Pioneering Intelligence PR Newswire
11.09.23 - PR Newswire
Flagship Pioneering Announces Appointment of Amanda Kay as Chief Business Development Officer
Flagship Pioneering Announces Appointment of Amanda Kay as Chief Business Development Officer PR Newswire
29.08.23 - PR Newswire
Invaio achieves first registration for citrus greening solution featuring Trecise™ technology
Invaio achieves first registration for citrus greening solution featuring Trecise™ technology PR Newswire
16.05.23 - PR Newswire
Flagship Pioneering Launches Metaphore Biotechnologies to Unlock the Therapeutic Potential of Biomimicry
Flagship Pioneering Launches Metaphore Biotechnologies to Unlock the Therapeutic Potential of Biomimicry PR Newswire
28.02.22 - PR Newswire
Alltrna Appoints Rare Disease Clinical Research Expert, Dr. Anne Pariser, as Vice President, Medical and Regulatory Affairs
Alltrna Appoints Rare Disease Clinical Research Expert, Dr. Anne Pariser, as Vice President, Medical and Regulatory Affairs PR Newswire
15.02.22 - PR Newswire
INVAIO SCIENCES STRENGTHENS ITS BOARD OF DIRECTORS WITH THE APPOINTMENT OF HUGH GRANT
INVAIO SCIENCES STRENGTHENS ITS BOARD OF DIRECTORS WITH THE APPOINTMENT OF HUGH GRANT PR Newswire
17.12.21 - PR Newswire
Omega Funds schließt den überzeichneten 650-Millionen-US-Dollar-Fonds VII ab, um in transformative Life-Science-Unternehmen zu investieren
Omega Funds schließt den überzeichneten 650-Millionen-​US-Dollar-Fonds VII ab, um in transformative Life-​Science-Unternehmen zu investieren PR Newswire
17.12.21 - PR Newswire
Omega Funds Closes Oversubscribed $650 Million Fund VII to Invest in Transformative Life Science Companies
Omega Funds Closes Oversubscribed $650 Million Fund VII to Invest in Transformative Life Science Companies - Adds Mike Powell, Ph.D., as Executive Partner & promotes ...
09.08.21 - PR Newswire
MaxCyte Signs Clinical and Commercial License with Sana Biotechnology
MaxCyte Signs Clinical and Commercial License with Sana Biotechnology Agreement represents MaxCyte's 14th strategic platform license (SPL) Sana will use MaxCyte's Flow ...
14.06.21 - PR Newswire
Dr. Stephen Hahn, 24th US FDA Commissioner and Former Chief Medical Executive at MD Anderson, joins Flagship Pioneering as Chief Medical Officer of Flagship's Preemptive Medicine and Health Security Initiative
Dr. Stephen Hahn, 24th US FDA Commissioner and Former Chief Medical Executive at MD Anderson, joins Flagship Pioneering as Chief Medical Officer of Flagship's Preemptive ...
25.05.21 - PR Newswire
Invaio Sciences Raises $88.9 Million to Accelerate the Transition to Biological Agriculture
Invaio Sciences Raises $88.9 Million to Accelerate the Transition to Biological Agriculture PR Newswire
19.05.21 - PR Newswire
Invaio Sciences Announces Key Agreement with Fundecitrus in Brazil to Combat Against Citrus Greening
Invaio Sciences Announces Key Agreement with Fundecitrus in Brazil to Combat Against Citrus Greening PR Newswire
30.03.21 - PR Newswire
Invaio Sciences Strengthens Leadership Team with Appointment of Peleg Chevion as President and Chief Commercial Officer
Invaio Sciences Strengthens Leadership Team with Appointment of Peleg Chevion as President and Chief Commercial Officer PR Newswire
25.02.21 - PR Newswire
Cellarity Raises $123 Million in Series B Funding to Pioneer a New Approach to Drug Discovery, Treating Disease at the Level of the Cell as Opposed to a Single Molecular Target
Cellarity Raises $123 Million in Series B Funding to Pioneer a New Approach to Drug Discovery, Treating Disease at the Level of the Cell as Opposed to a Single Molecular Target ...

Newssuche

Videos

newspaper
13.06.24 0,00%
Technical Trading: Zukauf-​Chance bei Top-Trade, wenn
Sugar No.11 Long Typ: Turbo Open End WKN: VV50DP Hebel: 5 Laufzeit: OpenEnd Einstieg: prozyklisch ... Mehr »